A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer

NCT01239732 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1021

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Paclitaxel
DRUG: Bevacizumab
DRUG: Carboplatin

Sponsor

Hoffmann-La Roche